Goldman Sachs upgrades CACI International stock rating to Buy on tech pivot

Goldman Sachs upgraded CACI International to Buy from Sell, raising its price target to $544 from $407, citing the company's strong defense sector positioning and strategic shift towards advanced technology products in high-growth budget areas. This upgrade follows CACI's robust Q4 2025 earnings, which significantly surpassed analyst expectations with an EPS of $8.4, and a 39% stock gain over the past six months. Goldman views CACI as the "best positioned name" in its group, noting its favorable valuation relative to competitors, with the tech-focused revenue mix expected to reduce contract risks and drive continued business wins.

Analysis

CACI International has received a significant endorsement from Goldman Sachs, which upgraded the stock from Sell to Buy and raised its price target to $544 from $407. The upgrade is underpinned by CACI's strategic pivot from expertise-based services to offering advanced, software-defined technology products in high-growth government budget areas such as signals intelligence, C4ISR, and electronic warfare. Goldman Sachs views this shift as a key driver for future business wins and reduced contract risk. The firm also highlights a favorable valuation, with CACI trading at 11.9x CY26 EV/EBITDA, which it considers less expensive than competitors Booz Allen Hamilton and Parsons. This positive outlook is supported by CACI's recent performance, including a strong fourth-quarter 2025 earnings report where EPS of $8.4 represented a 27.27% beat over forecasts, and a 39% stock price appreciation over the past six months. Other analysts are also positive, with Truist Securities raising its target to $575, while Raymond James maintains a Market Perform rating, acknowledging the company's "crisp" execution and solid guidance.

Key Decisions for Investors

• Investors could interpret the Goldman Sachs upgrade and strong earnings beat as validation of CACI's successful strategic shift, warranting a bullish re-evaluation of the stock's growth potential.
• Given the stock's 39% run-up over the past six months, it is prudent to monitor for continued execution on its technology-focused strategy and new contract wins to ensure the growth narrative remains intact.
• Consider the valuation argument presented by Goldman Sachs, as CACI's price relative to peers like Booz Allen and Parsons may offer a compelling entry point if its fundamental outperformance continues.